Crowe can help you establish a comprehensive, monitored 340B Drug Pricing Program. Our consultants, including experienced pharmacists and previous 340B coordinators and managers, help clients of all sizes maintain compliance and prepare for U.S. Health Resources & Services Administration (HRSA) and manufacturer audits through:
Crowe also offers independent audit services that deliver focused, objective audits backed by 340B expertise.
You want to make the most of it—and you don’t want to worry about HRSA audit findings. Our team knows the 340B program inside and out, and can help you every step of the way.
This automated solution helps streamline internal monitoring procedures by testing 100 percent of an organization’s 340B dispensations, while also helping identify areas for program optimization.
The 340B Program Monitor solution offers:
Preserving 340B Benefits for Safety Net Healthcare Providers
New Opportunities for 340B Program Expansion
The Future of Internal Audit Is Today
Is Your ACO Ready for Downside Risk?
Tap Internal Audit as a Hidden Asset
Advancing Healthcare: A Crowe LLP Resource Guide
Top 20 Healthcare Risks
Clinical Minute: Catheter-associated urinary tract infection (CAUTI)
Physician Payment Compliance: 3 Strategies for Avoiding Risk
Setting Audit Committee Goals